
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.320 | 0.320 | 0.000 |
Shares | 99.680 | 99.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.357 | 17.901 |
Price to Book | 2.715 | 2.969 |
Price to Sales | 2.132 | 2.199 |
Price to Cash Flow | 10.510 | 11.852 |
Dividend Yield | 1.875 | 2.077 |
5 Years Earnings Growth | 15.950 | 10.075 |
Name | Net % | Category Average |
---|---|---|
Technology | 27.690 | 23.529 |
Financial Services | 18.200 | 16.945 |
Healthcare | 12.710 | 12.932 |
Communication Services | 10.520 | 7.932 |
Industrials | 9.290 | 11.820 |
Consumer Cyclical | 7.690 | 10.485 |
Consumer Defensive | 6.460 | 7.530 |
Real Estate | 3.860 | 2.760 |
Basic Materials | 2.860 | 3.984 |
Utilities | 0.710 | 2.583 |
Number of long holdings: 170
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 6.48 | 203.92 | +1.64% | |
Microsoft | US5949181045 | 5.90 | 470.38 | +0.58% | |
NVIDIA | US67066G1040 | 5.30 | 141.72 | +1.24% | |
Mastercard | US57636Q1040 | 2.43 | 590.12 | +0.80% | |
Alphabet A | US02079K3059 | 2.12 | 173.68 | +3.25% | |
Alphabet C | US02079K1079 | 1.92 | 174.92 | +3.01% | |
Eli Lilly | US5324571083 | 1.71 | 769.88 | +0.55% | |
Novartis | CH0012005267 | 1.60 | 97.08 | +0.42% | |
TE Connectivity | IE000IVNQZ81 | 1.53 | 164.65 | +1.44% | |
Linde PLC | IE000S9YS762 | 1.51 | 414.600 | +0.53% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0461105529 | 2.96B | -14.53 | 7.49 | 10.19 | ||
LU2403432821 | 2.96B | -6.78 | - | - | ||
LU1819524072 | 393.81M | 1.48 | 2.78 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review